GUELPH, ON, April 5, 2023 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2022. Biorem's complete fiscal 2022 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Read more at newswire.caProvided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.